HB 25-1316
Fiscal Note
Legislative Council Staff
Nonpartisan Services for Colorado’s Legislature
HB 25-1316: CHANGES TO DEFINITIONS MONITORING OF RX DRUGS
Prime Sponsors:
Rep. Bradley; Carter
Sen. Exum; Rich
Published for: House Health & Human Services
Drafting number: LLS 25-0705
Fiscal Analyst:
Kristine McLaughlin, 303-866-4776
kristine.mclaughlin@coleg.gov
Version: Initial Fiscal Note
Date: April 3, 2025
Fiscal note status: The fiscal note reflects the introduced bill, which was recommended by the Statutory
Revision Committee.
Summary Information
Overview. The bill updates definitions related to substance abuse in state law regulating electronic
monitoring of prescription drugs.
No fiscal impact. The bill has no fiscal impact on state or local government.
Appropriations. No appropriation is required.
Table 1
State Fiscal Impacts
Type of Impact
Budget Year
FY 2025-26
Out Year
FY 2026-27
State Revenue $0 $0
State Expenditures $0 $0
Transferred Funds $0 $0
Change in TABOR Refunds $0 $0
Change in State FTE 0.0 FTE 0.0 FTE
Page 2
April 3, 2025 HB 25-1316
Summary of Legislation
The bill updates definitions related to substance abuse in state law regulating electronic
monitoring of prescription drugs by repealing the definition of “drug abuse” and adding a
definition of “substance use disorder.”
Assessment of No Fiscal Impact
The bill conforms definitions and references from previously passed legislation and will not
change the revenue or expenditures of any state agency or local government. For this reason,
the bill is assessed as having no fiscal impact.
Effective Date
The bill takes effect 90 days following adjournment of the General Assembly sine die, assuming
no referendum petition is filed.
State and Local Government Contacts
Regulatory Agencies
The revenue and expenditure impacts in this fiscal note represent changes from current law under the bill for each
fiscal year. For additional information about fiscal notes, please visit the General Assembly website.